EraCal
company
About
EraCal Therapeutics develops drugs to treat different diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
EraCal Therapeutics is a Swiss biotech company committed to cutting-edge science and medicine. EraCal develops drugs to treat different diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
Fr1M
EraCal has raised a total of
Fr1M
in funding over 2 rounds. Their latest funding was raised on
Oct 18, 2019 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 18, 2019 | Seed | — | 1 | — | — | Detail |
| Jun 4, 2019 | Seed | Fr1M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
EraCal is funded by 1 investors.
Life Sciences Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
